Means and method for aiding individuals to stop smoking
Patent 4255439 Issued on March 10, 1981. Estimated Expiration Date: 
July 13, 1999. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 13, 1999. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3146240 3236857 3850926 Propargyl-substituted 2-phenylamino-2-imidazolines and salts thereof 2-[N-phenyl-N-(cycloalkyl-methyl)-amino]-2-imidazolines and salts thereof Patent #: 4100292 InventorApplicationNo. 06/057288 filed on 07/13/1979US Classes:514/392, Divalent chalcogen or acyclic nitrogen double bonded at 2-position, or tautomeric equivalent514/231.2, Morpholines (i.e., fully hydrogenated 1,4- oxazines)514/400, At imidazole ring carbon514/813, Tobacco514/910AnorecticExaminersPrimary: Robinson, Douglas W.Attorney, Agent or FirmInternational ClassesA61K 31/415 (20060101)A61K 31/535 (20060101) AbstractIndividuals are aided in their desire to stop tobacco smoking and lose overweight by administering internally a combination of pharmaceuticals comprising an imidazoline derivative, such as clonidine hydrochloride, with an anorectic, such as phentermine resin.Other References
| |
